ORBIMED ADVISORS LLC Theravance Biopharma, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$0
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

+11.92%
quarter

Theravance Biopharma, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -1.37M shares -12.41M $10.14 0
Q2 2022 share Decrease -57.90% -1.88M shares -18.70M $9.06 1.37M
Q1 2022 share Decrease -45.52% -2.71M shares -34.90M $9.56 3.25M
Q4 2021 share Increase +1.35% 79.37K shares 22.39M $10.98 5.97M
Q3 2021 share Increase +29.17% 1.33M shares -22.64M $7.4 5.89M
Q2 2021 share Decrease -26.61% -1.65M shares -60.66M $14.52 4.56M
Q1 2021 share 0.00% 0 shares 16.41M $20.41 6.21M
Q4 2020 share 0.00% 0 shares 18.56M $17.77 6.21M
Q3 2020 share Increase +143.46% 3.66M shares 38.33M $14.79 6.21M
Q2 2020 share Increase +1107.53% 2.34M shares 48.72M $20.99 2.55M
Q1 2020 share Increase 0.00% 211.54K shares 4.88M $23.11 211.54K